Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose W Saldanha

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|March 7, 2002
Seven-transmembrane receptors: crystals clarifyZhi-Liang Lu, Jose W Saldanha, Edward C Hulme
Protein Engineering|October 5, 2002
A major IgE epitope-containing grass pollen allergen domain from Phl p 5 folds as a four-helix bundleOrnella Maglio, Jose W Saldanha, Susanne Vrtala, et al.
The FEBS Journal|August 24, 2007
Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesisPetra Mlcochová, Anna Plechanovová, Cyril Barinka, et al.
BMC Cancer|May 13, 2009
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancerWenqing Qi, Larry S Cooke, Amy Stejskal, et al.
Cancer Research|February 27, 2009
Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancerChristopher J Riley, Kevin P Engelhardt, Jose W Saldanha, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|March 7, 2002
Seven-transmembrane receptors: crystals clarifyZhi-Liang Lu, Jose W Saldanha, Edward C Hulme
Protein Engineering|October 5, 2002
A major IgE epitope-containing grass pollen allergen domain from Phl p 5 folds as a four-helix bundleOrnella Maglio, Jose W Saldanha, Susanne Vrtala, et al.
The FEBS Journal|August 24, 2007
Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesisPetra Mlcochová, Anna Plechanovová, Cyril Barinka, et al.
BMC Cancer|May 13, 2009
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancerWenqing Qi, Larry S Cooke, Amy Stejskal, et al.
Cancer Research|February 27, 2009
Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancerChristopher J Riley, Kevin P Engelhardt, Jose W Saldanha, et al.
Pageof 1